Lincoln Pharmaceuticals informs about disclosure

30 Nov 2022 Evaluate

Lincoln Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel & PACs.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

594.20 29.85 (5.29%)
01-Apr-2026 13:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.00
Dr. Reddys Lab 1223.40
Cipla 1196.80
Zydus Lifesciences 862.40
Lupin 2273.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×